AstraZeneca plc Stock Price, News & Analysis (LON:AZN)

GBX 4,975 -36.00 (-0.72 %)
(As of 11/18/2017 01:46 AM ET)
Previous CloseGBX 4,975
Today's RangeGBX 5,071.41 - GBX 4,943
52-Week RangeGBX 3,996 - GBX 5,520
Volume1.50 million shs
Average Volume2.12 million shs
Market Capitalization£62.86 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About AstraZeneca plc (LON:AZN)

AstraZeneca plc logoAstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVMD, it is expanding its portfolio into the cardiovascular-renal area with late-stage assets, such as ZS-9 and roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). The Company has approximately 40 projects in Phase I, including 29 new molecular entities (NMEs), and 11 oncology combination projects. It has approximately 40 projects in Phase II, including 25 NMEs; four significant additional indications for projects that have reached phase II, and seven oncology combination projects.


Industry, Sector and Symbol:
  • Industry: Pharmaceuticals
  • Sub-Industry: N/A
  • Sector: Pharmaceuticals - NEC
  • Symbol: LON:AZN
  • CUSIP: N/A
  • Web: www.astrazeneca.com
Profitability:
  • Trailing EPS: GBX 2.12
  • Net Margins: 8.83%
  • Return on Equity: 14.36%
  • Return on Assets: 2.84%
Misc:
  • Outstanding Shares: 1,270,000,000
 

Frequently Asked Questions for AstraZeneca plc (LON:AZN)

What is AstraZeneca plc's stock symbol?

AstraZeneca plc trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How often does AstraZeneca plc pay dividends? What is the dividend yield for AstraZeneca plc?

AstraZeneca plc announced a dividend on Thursday, July 27th. Shareholders of record on Thursday, August 10th will be given a dividend of GBX 68.90 per share on Monday, September 11th. This represents a yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 10th. The official announcement can be viewed at this link. View AstraZeneca plc's Dividend History.

Where is AstraZeneca plc's stock going? Where will AstraZeneca plc's stock price be in 2017?

21 Wall Street analysts have issued 12-month price objectives for AstraZeneca plc's shares. Their forecasts range from GBX 3,800 to GBX 6,300. On average, they anticipate AstraZeneca plc's share price to reach GBX 5,221.40 in the next year. View Analyst Ratings for AstraZeneca plc.

Who are some of AstraZeneca plc's key competitors?

Who are AstraZeneca plc's key executives?

AstraZeneca plc's management team includes the folowing people:

  • Pascal Soriot, Executive Director and Chief Executive Officer (Age 57)
  • Marc Dunoyer, Executive Director, Chief Financial Officer (Age 64)
  • Fiona Cicconi, Executive Vice-President, Human Resources
  • Sean Bohen M.D., Ph.D., Chief Medical Officer, Executive Vice President - Global Medicines Development
  • Pam P. Cheng, Executive Vice President - Operations and Information Technology (Age 45)
  • Ruud Dobber, Executive Vice President, North America
  • Bahija Jallal Ph.D., Executive Vice President, MedImmune
  • Mark Mallon, Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs Executive Vice-President, International West
  • Menelas Pangalos, Executive Vice President - IMED Biotech Unit and Global Business Development
  • Leon Wang, Executive Vice President - Asia Pacific

How do I buy AstraZeneca plc stock?

Shares of AstraZeneca plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca plc's stock price today?

One share of AstraZeneca plc stock can currently be purchased for approximately GBX 4,975.

How big of a company is AstraZeneca plc?

AstraZeneca plc has a market capitalization of £62.86 billion.

How can I contact AstraZeneca plc?

AstraZeneca plc's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.


MarketBeat Community Rating for AstraZeneca plc (LON AZN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  917 (Vote Outperform)
Underperform Votes:  1,278 (Vote Underperform)
Total Votes:  2,195
MarketBeat's community ratings are surveys of what our community members think about AstraZeneca plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for AstraZeneca plc (LON:AZN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 6 Hold Ratings, 12 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: GBX 5,221.40

Consensus Price Target History for AstraZeneca plc (LON:AZN)

Price Target History for AstraZeneca plc (LON:AZN)

Analysts' Ratings History for AstraZeneca plc (LON:AZN)

Show:
DateFirmActionRatingPrice TargetDetails
11/16/2017Jefferies Group LLCReiterated RatingHoldGBX 5,100View Rating Details
11/16/2017HSBC Holdings PLCBoost Price TargetReduceGBX 4,340 -> GBX 4,380View Rating Details
11/6/2017InvestecBoost Price TargetBuyGBX 4,900 -> GBX 5,500View Rating Details
11/10/2017Morgan StanleySet Price TargetNeutralGBX 5,000View Rating Details
11/10/2017S&P GlobalSet Price TargetNeutralGBX 5,000View Rating Details
11/10/2017Kepler Capital MarketsReiterated RatingBuyGBX 5,250View Rating Details
11/10/2017J P Morgan Chase & CoReiterated RatingNeutralView Rating Details
11/10/2017Deutsche Bank AGReiterated RatingBuyGBX 5,600View Rating Details
11/9/2017Shore CapitalReiterated RatingHoldView Rating Details
11/8/2017Citigroup Inc.Reiterated RatingBuyView Rating Details
11/2/2017The Goldman Sachs Group, Inc.Set Price TargetSellGBX 3,800View Rating Details
11/1/2017Berenberg BankReiterated RatingBuyGBX 5,800View Rating Details
11/1/2017Liberum CapitalReiterated RatingHoldGBX 5,000View Rating Details
10/16/2017Credit Suisse GroupUpgradeNeutral -> OutperformGBX 4,800 -> GBX 5,800View Rating Details
10/5/2017Barclays PLCReiterated RatingOverweightGBX 6,300View Rating Details
9/25/2017BNP ParibasSet Price TargetBuyGBX 5,800View Rating Details
9/25/2017Sanford C. BernsteinSet Price TargetBuyGBX 5,780View Rating Details
9/21/2017Societe GeneraleReiterated RatingBuyView Rating Details
9/11/2017Bryan, Garnier & CoUpgradeBuyGBX 4,700 -> GBX 5,380View Rating Details
9/6/2017NatixisUpgradeNeutral -> BuyGBX 5,000 -> GBX 5,738View Rating Details
7/28/2017Beaufort SecuritiesDowngradeSellGBX 3,900View Rating Details
6/24/2016Independent Research GmbHSet Price TargetSellGBX 3,650View Rating Details
5/10/2016Oddo SecuritiesReiterated RatingBuyGBX 5,400View Rating Details
5/5/2016Charles StanleyUpgradeStrong-BuyView Rating Details
3/23/2016NomuraLower Price TargetHoldGBX 4,880 -> GBX 4,350View Rating Details
2/12/2016Baader BankReiterated RatingHoldGBX 4,400View Rating Details
2/9/2016AlphaValueUpgradeBuyGBX 4,640View Rating Details
2/4/2016S&P Equity ResearchSet Price TargetNeutralGBX 4,500View Rating Details
2/2/2016HandelsbankenReiterated RatingAccumulateGBX 5,220.30View Rating Details
1/28/2016Pareto SecuritiesReiterated RatingSellGBX 3,855.35View Rating Details
1/27/2016SwedbankReiterated RatingBuyGBX 5,115.47View Rating Details
1/13/2016Nordea Equity ResearchReiterated RatingHoldGBX 4,698.35View Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History for AstraZeneca plc (LON:AZN)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for AstraZeneca plc (LON:AZN)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for AstraZeneca plc (LON AZN)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/27/2017GBX 68.901.35%8/10/20178/10/20179/11/2017
2/2/2017GBX 150.203.52%2/16/20172/16/20173/20/2017
7/28/2016GBX 68.701.37%8/11/20168/11/20169/12/2016
2/4/2016GBX 1313.16%2/18/20162/18/20163/21/2016
7/30/2015GBX 57.501.33%8/13/20158/13/20159/14/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for AstraZeneca plc (LON AZN)

Insider Trades by Quarter for AstraZeneca plc (LON:AZN)

Insider Trades by Quarter for AstraZeneca plc (LON AZN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2017Nazneen RahmanInsiderBuy39GBX 4,370£1,704.30
10/27/2015Courtois,Jean-PhilippeInsiderBuy900GBX 4,423£39,807
8/28/2015Soriot,PascalInsiderBuy76,300GBX 3,960£3,021,480
5/7/2015Marc DunoyerInsiderBuy10,000GBX 4,397£439,700
4/30/2015Ann CairnsInsiderBuy1,100GBX 4,455£49,005
4/29/2015Shriti VaderaInsiderBuy3,500GBX 4,563£159,705
4/28/2015Graham ChipchaseInsiderBuy1,100GBX 4,606£50,666
4/27/2015Bruce BurlingtonInsiderBuy600GBX 4,662£27,972
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AstraZeneca plc (LON AZN)

Source:
DateHeadline
AstraZeneca plc (AZN) Earns Hold Rating from Jefferies Group LLCAstraZeneca plc (AZN) Earns Hold Rating from Jefferies Group LLC
www.americanbankingnews.com - November 19 at 12:16 AM
Earnings Visibility Make AstraZeneca (AZN) a Buy - Investorplace.comEarnings Visibility Make AstraZeneca (AZN) a Buy - Investorplace.com
investorplace.com - November 18 at 4:12 PM
AstraZeneca’s Respiratory Segment in 3Q17AstraZeneca’s Respiratory Segment in 3Q17
finance.yahoo.com - November 17 at 4:01 PM
Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets 2 FDA Approvals, GW Pharmaceuticals Price Target LoweredYour Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets 2 FDA Approvals, GW Pharmaceuticals' Price Target Lowered
seekingalpha.com - November 16 at 11:46 AM
AstraZeneca: FDA Approves Faslodex With Abemaciclib For Advanced Breast CancerAstraZeneca: FDA Approves Faslodex With Abemaciclib For Advanced Breast Cancer
www.rttnews.com - November 16 at 11:46 AM
AstraZenecas (AZN) Asthma Drug Benralizumab Approved by FDAAstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA
finance.yahoo.com - November 16 at 11:46 AM
FDA OKs AstraZenecas asthma med benralizumab - Seeking AlphaFDA OKs AstraZeneca's asthma med benralizumab - Seeking Alpha
seekingalpha.com - November 15 at 1:38 AM
U.S. FDA approves AstraZenecas asthma drugU.S. FDA approves AstraZeneca's asthma drug
finance.yahoo.com - November 15 at 1:38 AM
Novo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes DayNovo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day
finance.yahoo.com - November 14 at 4:48 PM
AstraZeneca Plc – Value Analysis (LONDON:AZN) : November 13, 2017AstraZeneca Plc – Value Analysis (LONDON:AZN) : November 13, 2017
finance.yahoo.com - November 14 at 1:45 AM
AstraZeneca plc (AZN) Given Buy Rating at Deutsche Bank AGAstraZeneca plc (AZN) Given Buy Rating at Deutsche Bank AG
www.americanbankingnews.com - November 12 at 10:52 PM
AstraZeneca plc (AZN) Stock Rating Reaffirmed by J P Morgan Chase & CoAstraZeneca plc (AZN) Stock Rating Reaffirmed by J P Morgan Chase & Co
www.americanbankingnews.com - November 12 at 10:20 PM
AstraZeneca plc (AZN) Given Buy Rating at Kepler Capital MarketsAstraZeneca plc (AZN) Given Buy Rating at Kepler Capital Markets
www.americanbankingnews.com - November 12 at 6:32 PM
Edited Transcript of AZN.L earnings conference call or presentation 9-Nov-17 12:00pm GMTEdited Transcript of AZN.L earnings conference call or presentation 9-Nov-17 12:00pm GMT
finance.yahoo.com - November 11 at 12:51 PM
Morgan Stanley Analysts Give AstraZeneca plc (AZN) a GBX 5,000 Price TargetMorgan Stanley Analysts Give AstraZeneca plc (AZN) a GBX 5,000 Price Target
www.americanbankingnews.com - November 10 at 11:24 AM
AstraZeneca plc (AZN) Given a GBX 5,000 Price Target at S&P GlobalAstraZeneca plc (AZN) Given a GBX 5,000 Price Target at S&P Global
www.americanbankingnews.com - November 10 at 11:24 AM
AstraZeneca Plc breached its 50 day moving average in a Bearish Manner : AZN-GB : November 10, 2017AstraZeneca Plc breached its 50 day moving average in a Bearish Manner : AZN-GB : November 10, 2017
finance.yahoo.com - November 10 at 9:33 AM
AstraZeneca (AZN) Misses Q3 Earnings, Tweaks 2017 EPS View - NasdaqAstraZeneca (AZN) Misses Q3 Earnings, Tweaks 2017 EPS View - Nasdaq
www.nasdaq.com - November 9 at 3:28 PM
AstraZeneca plc (AZN) Given a GBX 4,550 Price Target by UBS AG AnalystsAstraZeneca plc (AZN) Given a GBX 4,550 Price Target by UBS AG Analysts
www.americanbankingnews.com - November 9 at 12:24 PM
AstraZeneca plc (AZN) PT Raised to GBX 5,500 at InvestecAstraZeneca plc (AZN) PT Raised to GBX 5,500 at Investec
www.americanbankingnews.com - November 6 at 3:41 PM
Why I’d buy AstraZeneca plc over this soaring growth stockWhy I’d buy AstraZeneca plc over this soaring growth stock
www.fool.co.uk - November 4 at 5:56 PM
AstraZeneca (AZN) Upgraded to Buy from a Hold - Investorplace.comAstraZeneca (AZN) Upgraded to Buy from a Hold - Investorplace.com
www.investorplace.com - November 3 at 4:48 PM
AstraZeneca plc (AZN) Rating Reiterated by Berenberg BankAstraZeneca plc (AZN) Rating Reiterated by Berenberg Bank
www.americanbankingnews.com - November 1 at 9:38 PM
AstraZeneca asthma drug disappoints in trialsAstraZeneca asthma drug disappoints in trials
www.marketwatch.com - November 1 at 4:54 PM
AstraZeneca plc (AZN) Receives Consensus Rating of "Hold" from BrokeragesAstraZeneca plc (AZN) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - October 29 at 5:38 AM
Earnings Growth Restricts AstraZeneca (AZN) Rating - Investorplace.comEarnings Growth Restricts AstraZeneca (AZN) Rating - Investorplace.com
investorplace.com - October 28 at 4:38 AM
Quant Score Restricts AstraZeneca (AZN) Rating - Investorplace.comQuant Score Restricts AstraZeneca (AZN) Rating - Investorplace.com
www.investorplace.com - October 20 at 11:08 PM
AstraZeneca plc (AZN) Given a GBX 4,700 Price Target at Morgan StanleyAstraZeneca plc (AZN) Given a GBX 4,700 Price Target at Morgan Stanley
www.americanbankingnews.com - October 20 at 11:44 AM
China biotechs coming out party masks long road aheadChina biotech's 'coming out party' masks long road ahead
finance.yahoo.com - October 19 at 3:40 AM
Hutchison China MediTech, AstraZeneca Present Savolitinib Combo DataHutchison China MediTech, AstraZeneca Present Savolitinib Combo Data
www.morningstar.co.uk - October 18 at 10:39 PM
TOP NEWS: AstraZenecas Imfinzi Granted Priority Review In Lung CancerTOP NEWS: AstraZeneca's Imfinzi Granted Priority Review In Lung Cancer
www.morningstar.co.uk - October 18 at 5:38 PM
AstraZeneca plcs (AZN) "Hold" Rating Reiterated at Shore CapitalAstraZeneca plc's (AZN) "Hold" Rating Reiterated at Shore Capital
www.americanbankingnews.com - October 17 at 6:30 AM
Novo Nordisk diabetes drug works; no heart risk-FDA reviewNovo Nordisk diabetes drug works; no heart risk-FDA review
www.reuters.com - October 16 at 10:05 PM
AstraZeneca plc (AZN) PT Set at GBX 5,800 by Credit Suisse GroupAstraZeneca plc (AZN) PT Set at GBX 5,800 by Credit Suisse Group
www.americanbankingnews.com - October 16 at 7:20 AM
Drug Companies Fear Brexit Will Hit Medicine TradeDrug Companies Fear Brexit Will Hit Medicine Trade
finance.yahoo.com - October 16 at 2:04 AM
5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings - Yahoo Finance5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings - Yahoo Finance
finance.yahoo.com - October 15 at 9:04 PM
Hold Rating for AstraZeneca (AZN) Retained - Investorplace.com (blog)Hold Rating for AstraZeneca (AZN) Retained - Investorplace.com (blog)
investorplace.com - October 15 at 2:06 AM
AstraZeneca plc (AZN) Given a GBX 4,550 Price Target at UBS AGAstraZeneca plc (AZN) Given a GBX 4,550 Price Target at UBS AG
www.americanbankingnews.com - October 9 at 10:06 AM
AstraZeneca plcs (AZN) "Overweight" Rating Reiterated at Barclays PLCAstraZeneca plc's (AZN) "Overweight" Rating Reiterated at Barclays PLC
www.americanbankingnews.com - October 8 at 11:16 AM
AstraZeneca plc (AZN) Rating Reiterated by Deutsche Bank AGAstraZeneca plc (AZN) Rating Reiterated by Deutsche Bank AG
www.americanbankingnews.com - October 8 at 10:02 AM
FTSE scales two-month peakFTSE scales two-month peak
finance.yahoo.com - October 6 at 8:38 AM
Drug industry gives up legal battle over new UK cost curbsDrug industry gives up legal battle over new UK cost curbs
finance.yahoo.com - October 5 at 2:23 PM
AstraZeneca plc (AZN) Given Average Rating of "Hold" by AnalystsAstraZeneca plc (AZN) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - October 4 at 6:52 AM
AstraZenecas Bevespi Improves Lung Function in Phase III Study - NasdaqAstraZeneca's Bevespi Improves Lung Function in Phase III Study - Nasdaq
www.nasdaq.com - September 28 at 12:45 AM
AstraZenecas Bevespi Improves Lung Function in Phase III StudyAstraZeneca's Bevespi Improves Lung Function in Phase III Study
www.zacks.com - September 27 at 7:44 PM
AstraZeneca plc (AZN) Given a GBX 5,800 Price Target at BNP ParibasAstraZeneca plc (AZN) Given a GBX 5,800 Price Target at BNP Paribas
www.americanbankingnews.com - September 25 at 4:44 PM
Berenberg Bank Analysts Give AstraZeneca plc (AZN) a GBX 5,800 Price TargetBerenberg Bank Analysts Give AstraZeneca plc (AZN) a GBX 5,800 Price Target
www.americanbankingnews.com - September 24 at 2:08 PM
Societe Generale Reiterates "Buy" Rating for AstraZeneca plc (AZN)Societe Generale Reiterates "Buy" Rating for AstraZeneca plc (AZN)
www.americanbankingnews.com - September 23 at 5:22 PM
Why I’d ditch this defensive dividend stock to buy AstraZeneca plcWhy I’d ditch this defensive dividend stock to buy AstraZeneca plc
www.msn.com - September 18 at 4:43 PM
AstraZeneca plc (AZN) PT Set at GBX 4,900 by Jefferies Group LLCAstraZeneca plc (AZN) PT Set at GBX 4,900 by Jefferies Group LLC
www.americanbankingnews.com - September 18 at 6:30 AM

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

AstraZeneca plc (LON AZN) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.